BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31868307)

  • 1. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Gao G; Feng L; Zhang D; Song C; Zhu C; Song W; Zhao Y; Xu B; Yin D; Dou K
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):639-645. PubMed ID: 29542281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.
    Kim J; Lee JM; Choi KH; Rhee TM; Hwang D; Park J; Ahn C; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Choi SH; Gwon HC
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29449272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
    Alidoosti M; Saroukhani S; Lotfi-Tokaldany M; Jalali A; Sobh-Rakhshankhah A
    Cardiovasc Revasc Med; 2016; 17(5):308-12. PubMed ID: 27198530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.
    Lee JM; Hwang D; Choi KH; Lee HJ; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009232. PubMed ID: 32895005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of residual SYNTAX score on clinical outcomes after incomplete revascularisation percutaneous coronary intervention: a large single-centre study.
    Song Y; Gao Z; Tang X; Jiang P; Xu J; Yao Y; Li J; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
    EuroIntervention; 2017 Nov; 13(10):1185-1193. PubMed ID: 28760723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
    Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
    EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney Disease.
    Hwang D; Kang J; Yang HM; Yang S; Park J; Han JK; Kang HJ; Koo BK; Kim HS
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007907. PubMed ID: 31345065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the residual SYNTAX score to predict long term outcome in acute coronary syndrome patients underwent percutaneous coronary intervention].
    Song Y; Xu JJ; Tang XF; Ma YL; Yao Y; He C; Wang HH; Liu R; Xu N; Jiang P; Jiang L; Zhao XY; Gao Z; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(7):502-507. PubMed ID: 28260288
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study.
    Almeida AS; Fuchs SC; Fuchs FC; Silva AG; Lucca MB; Scopel S; Fuchs FD
    Vasc Health Risk Manag; 2020; 16():285-297. PubMed ID: 32764949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incremental Prognostic Value of the Clinical Residual SYNTAX Score for Patients With Chronic Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yan L; Li P; Wang Y; Han D; Li S; Jiang M; Cao X; Cao F
    Front Cardiovasc Med; 2021; 8():647720. PubMed ID: 33937361
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.
    Takahashi K; Serruys PW; Gao C; Ono M; Wang R; Thuijs DJFM; Mack MJ; Curzen N; Mohr FW; Davierwala P; Milojevic M; Wykrzykowska JJ; de Winter RJ; Sharif F; Onuma Y; Head SJ; Kappetein AP; Morice MC; Holmes DR;
    Circulation; 2021 Jul; 144(2):96-109. PubMed ID: 34011163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease.
    Choi KH; Lee JM; Koo BK; Nam CW; Shin ES; Doh JH; Rhee TM; Hwang D; Park J; Zhang J; Kim KJ; Hu X; Wang J; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Akasaka T
    JACC Cardiovasc Interv; 2018 Feb; 11(3):237-245. PubMed ID: 29361444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.